Treatment patterns and outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia: a single center study from Oman - Top-Institutions - MDSpire

Treatment patterns and outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia: a single center study from Oman

  • By

  • Noor Al-Rawahi

  • Bushra Salman

  • Dhanalekshmi Unnikrishnan Meenakshi

  • Murtadha Al-Khabori

  • Mohammed Al-Hanini

  • Salam Al-Kindi

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Sultan Qaboos University Hospital
    Sultan Qaboos University Hospital

    Muscat, Oman

    Key Differentiators

    • Hematology

  • #2

    College of Medicine and Health Sciences, Sultan Qaboos University
    College of Medicine and Health Sciences, Sultan Qaboos University

    Muscat, Oman

    Key Differentiators

    • Hematology

  • #3

    Cancer Treatment Centers of America
    Cancer Treatment Centers of America

    Tulsa, Oklahoma

    Key Differentiators

    • Hematology

  • #4

    Hospital 12 de Octubre
    Hospital 12 de Octubre

    Madrid, Spain

    Key Differentiators

    • Hematology

  • #5

    EMEA Collaborative Network
    EMEA Collaborative Network

    Various, Europe

    Key Differentiators

    • Hematology

Original Source(s)

Treatment patterns and outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia: a single center study from Oman

  • by Noor Al-Rawahi, Bushra Salman, Dhanalekshmi Unnikrishnan Meenakshi, Murtadha Al-Khabori, Mohammed Al-Hanini, Salam Al-Kindi

  • July 15, 2026

Related Content

Gut microbiota induces immune-related alterations in gene expression, RNA methylation, and metabolism in glioblastoma revealed by single-cell and spatial multi-omics

Emerging role of ETV4 in colorectal cancer: from molecular mechanisms to clinical implications

Galectins at the crossroads of tumor immunity, metabolism, and metastasis: mechanisms, therapeutic resistance, and translational opportunities